![]() |
![]() OKLAHOMA SPOTLIGHT, page 4
Edmond Courts Adding to its reputation, Edmond recently snared the new research facilities of Nanobiomagnetics (NBMI), a firm engaged in the development and commercialization of magnetic nano-particle technologies for human health applications in an emerging area of nanobiomedicine referred to as Organ-Assisting Devices (OADs). Applications of OADs include vectored drug delivery, biofunctional switches, tissue repair and imaging/diagnostic materials. The company's initial focus is the vectored delivery of cardiac therapeutics for the treatment and prevention of atrial fibrillation, ischemia, plaque formation and blood clotting. "The new laboratory space will significantly expand NBMI's capabilities in the development of magnetically responsive nanoparticles that can be adapted to a wide range of human health applications," says Charles Seeney, CEO and co-founder. NBMI and the University of Oklahoma have established a collaborative research agreement under which both have agreed to explore various applications of nanotechnology. "This brings us another step closer to the establishment of an Oklahoma Nanobiotechnology Center," says Dr. Kenneth Dormer, professor of physiol ogy at Oklahoma University Health Science Center and NBMI's other co-founder. |
©2003 Conway Data, Inc. All rights reserved. SiteNet data is from many sources and not warranted to be accurate or current.
|